http://www.fda.gov/cder/drug/infopage/lotronex/lotronex.htm
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
This page presents information for women using the prescription drug Lotronex (alosetron hydrochloride) for treatment of the diarrhea-predominant form of irritable bowel syndrome (IBS). The guide is designed to help users understand the rare but serious risks of the drug and how they can recognize those risks and take action to prevent serious harm. Updated information for health professionals who prescribe Lotronex is also available here.